Ahmed SM, Luo L, Namani A, Wang XJ (1863) Tang X (2017) Nrf2 signaling pathway: pivotal roles in inflammation. Biochim Biophys Acta Mol Basis Dis 2:585–597

Google Scholar 

Cuadrado A, Martin-Moldes Z, Ye J, Lastres-Becker I (2014) Transcription factors NRF2 and NF-kappaB are coordinated effectors of the rho family, GTP-binding protein RAC1 during inflammation. J Biol Chem 289:15244–15258

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dubbelaar ML, Kracht L, Eggen BJL, Boddeke E (2018) The kaleidoscope of microglial phenotypes. Front Immunol 9:1753

Article  PubMed  PubMed Central  Google Scholar 

Guo H, Callaway JB, Ting JP (2015) Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21:677–687

Article  PubMed  PubMed Central  Google Scholar 

Haque ME, Akther M, Jakaria M, Kim IS, Azam S, Choi DK (2020) Targeting the microglial NLRP3 inflammasome and its role in Parkinson’s disease. Mov Disord 35:20–33

Article  CAS  PubMed  Google Scholar 

Harada N, Kanayama M, Maruyama A, Yoshida A, Tazumi K, Hosoya T, Mimura J, Toki T, Maher JM, Yamamoto M, Itoh K (2011) Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch Biochem Biophys 508:101–109

Article  CAS  PubMed  Google Scholar 

He Y, Hara H, Nunez G (2016) Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci 41:1012–1021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT (2013) NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 493:674–678

Article  CAS  PubMed  Google Scholar 

Hennig P, Garstkiewicz M, Grossi S, Di Filippo M, French LE, Beer HD (2018) The crosstalk between Nrf2 and inflammasomes. Int J Mol Sci 19:562

Article  PubMed  PubMed Central  Google Scholar 

Holbrook JA, Jarosz-Griffiths HH, Caseley E, Lara-Reyna S, Poulter JA, Williams-Gray CH, Peckham D, McDermott MF (2021) Neurodegenerative disease and the NLRP3 inflammasome. Front Pharmacol 12:643254

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M (2000) Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275:16023–16029

Article  CAS  PubMed  Google Scholar 

Iso T, Suzuki T, Baird L, Yamamoto M (2016) Absolute amounts and status of the Nrf2-Keap1-Cul3 complex within cells. Mol Cell Biol 36:3100–3112

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jo EK, Kim JK, Shin DM, Sasakawa C (2016) Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol 13:148–159

Article  CAS  PubMed  Google Scholar 

Jones JJ, Fan J, Nathens AB, Kapus A, Shekhman M, Marshall JC, Parodo J, Rotstein OD (1999) Redox manipulation using the thiol-oxidizing agent diethyl maleate prevents hepatocellular necrosis and apoptosis in a rodent endotoxemia model. Hepatology 30:714–724

Article  CAS  PubMed  Google Scholar 

Kang KW, Pak YM, Kim ND (1999) Diethylmaleate and buthionine sulfoximine, glutathione-depleting agents, differentially inhibit expression of inducible nitric oxide synthase in endotoxemic mice. Nitric Oxide 3:265–271

Article  CAS  PubMed  Google Scholar 

Kano SI, Choi EY, Dohi E, Agarwal S, Chang DJ, Wilson AM, Lo BD, Rose IVL, Gonzalez S, Imai T, Sawa A (2019) Glutathione S-transferases promote proinflammatory astrocyte-microglia communication during brain inflammation. Sci Signal 12:2124

Article  Google Scholar 

Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, Tanaka N, Moriguchi T, Motohashi H, Nakayama K, Yamamoto M (2016) Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun 7:11624

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krafczyk N, Klotz LO (2022) FOXO transcription factors in antioxidant defense. IUBMB Life 74:53–61

Article  CAS  PubMed  Google Scholar 

Mamik MK, Power C (2017) Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts. Brain 140:2273–2285

Article  PubMed  Google Scholar 

Man SM, Kanneganti TD (2015) Regulation of inflammasome activation. Immunol Rev 265:6–21

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E (2018) Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov 17:588–606

Article  CAS  PubMed  Google Scholar 

Nathens AB, Marshall JC, Watson RW, Dackiw AP, Rotstein OD (1996) Diethylmaleate attenuates endotoxin-induced lung injury. Surgery 120:360–366

Article  CAS  PubMed  Google Scholar 

Prinz M, Jung S, Priller J (2019) Microglia biology: one century of evolving concepts. Cell 179:292–311

Article  CAS  PubMed  Google Scholar 

Righi M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani A, Donini SD, Ricciardi-Castagnoli P (1989) Monokine production by microglial cell clones. Eur J Immunol 19:1443–1448

Article  CAS  PubMed  Google Scholar 

Robertson H, Dinkova-Kostova AT, Hayes JD (2020) NRF2 and the ambiguous consequences of its activation during initiation and the subsequent stages of tumourigenesis. Cancers (Basel) 12:3609

Article  CAS  PubMed  Google Scholar 

Sarkar S, Malovic E, Harishchandra DS, Ghaisas S, Panicker N, Charli A, Palanisamy BN, Rokad D, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2017) Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson’s disease. NPJ Parkinsons Dis 3:30

Article  PubMed  PubMed Central  Google Scholar 

Satoh T, Trudler D, Oh CK, Lipton SA (2022) Potential therapeutic use of the rosemary diterpene carnosic acid for Alzheimer’s disease, Parkinson’s disease, and long-COVID through NRF2 activation to counteract the NLRP3 inflammasome. Antioxidants. https://doi.org/10.3390/antiox11010124

Article  PubMed  PubMed Central  Google Scholar 

Silva-Islas CA, Maldonado PD (2018) Canonical and non-canonical mechanisms of Nrf2 activation. Pharmacol Res 134:92–99

Article  CAS  PubMed  Google Scholar 

Song N, Li T (2018) Regulation of NLRP3 inflammasome by phosphorylation. Front Immunol 9:2305

Article  PubMed  PubMed Central  Google Scholar 

Stansley B, Post J, Hensley K (2012) A comparative review of cell culture systems for the study of microglial biology in Alzheimer’s disease. J Neuroinflam 9:115

Article  Google Scholar 

Swanson KV, Deng M, Ting JP (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19:477–489

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taguchi K, Yamamoto M (2020) The KEAP1-NRF2 system as a molecular target of cancer treatment. Cancers. https://doi.org/10.3390/cancers13010046

Article  PubMed  PubMed Central  Google Scholar 

Timmerman R, Burm SM, Bajramovic JJ (2018) An overview of in vitro methods to study microglia. Front Cell Neurosci 12:242

Article  PubMed  PubMed Central  Google Scholar 

Tonelli C, Chio IIC, Tuveson DA (2018) Transcriptional regul Nrf2. Antioxid Redox Signal 29:1727–1745

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tufekci KU, Ercan I, Isci KB, Olcum M, Tastan B, Gonul CP, Genc K, Genc S (2021) Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration. Immunol Lett 233:20–30

Article  CAS  PubMed  Google Scholar 

Ulasov AV, Rosenkranz AA, Georgiev GP, Sobolev AS (2022) Nrf2/Keap1/ARE signaling: towards specific regulation. Life Sci 291:120111

Article  CAS  PubMed  Google Scholar 

Voet S, Srinivasan S, Lamkanfi M, van Loo G (2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med 11:e10248

Article  PubMed  PubMed Central